leadf
logo-loader
viewPortage Biotech

Portage Biotech to begin trading its shares on the Nasdaq February 25th

Portage Biotech Inc (CSE:PBT) (NASDAQ:PRTG) CEO Dr Ian Walters tells Proactive the clinical stage immuno-oncology company is looking forward to trading its shares on the Nasdaq Stock Exchange on February 25th.

Dr Walters explains how the Toronto-based group's listing on the Nasdaq made sense, as it now has 'momentum' going into clinical data readouts from its three lead assets. He expects the listing to expand the investor base and better approach specialist investors within the biotech sector.

Quick facts: Portage Biotech

Price: - -

CSE:PBT
Market: CSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Star Royalties finding success with a fresh approach including a carbon...

Star Royalties (CVE: STRR) CEO Alex Pernin joined Steve Darling from Proactive to bring detail about the royalty and streaming company that takes a different approach to that other in that space. Pernin talks about those differences and the fact they have created a carbon credit royalty that...

6 minutes ago

2 min read